Interleukin-2-associated bullous drug dermatosis.
Hofmann
M
M
Audring
H
H
Sterry
W
W
Trefzer
U
U
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D003937:Diagnosis, Differential; D003875:Drug Eruptions / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects*; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000556:secondary; D009362:Neoplasm Metastasis; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D013964:Thyroid Neoplasms / Q000188:drug therapy / Q000556:secondary
D000970:Antineoplastic Agents; D007376:Interleukin-2